Report: FDA Set to Authorize Pfizer COVID-19 Shot for Ages 12-15 Early Next Week

The U.S. Food and Drug Administration is preparing to authorize Pfizer Inc and German partner BioNTech SE’s COVID-19 vaccine for adolescents aged between 12 and 15 years by early next week, the New York Times reported on Monday.
Source: News Max

 5 total views,  1 views today

Leave a Reply

If providing this article has been helpful for you, please consider a donation.